论文部分内容阅读
706代血浆即羟乙基淀粉制剂,为一种新的醣类代血浆。具有无抗原,无热原,无毒性,原料广,价格低等优点,已于1970年试制成功。经用于33例冠心病(男30,女3,50岁以上者31例),结果有效17例,显效9例,总有效率为78.8%。部分病人血脂下
706 generation of plasma that is hydroxyethyl starch preparation, a new type of carbohydrate on behalf of plasma. With no antigen, no pyrogen, non-toxic, wide raw materials, low prices, has been trial production in 1970. Used in 33 cases of coronary heart disease (30 males, 3 females, 3,50 years old and 31 cases), the results were effective in 17 cases, markedly effective in 9 cases, the total effective rate was 78.8%. Some patients under the blood lipid